120 related articles for article (PubMed ID: 3924157)
21. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
22. Cervical cancers diagnosed after negative results on cervical cytology: perspective in the 1980s.
Mitchell H; Medley G; Giles G
BMJ; 1990 Jun; 300(6740):1622-6. PubMed ID: 2372641
[TBL] [Abstract][Full Text] [Related]
23. Optimal frequency of screening for cervical cancer: a Toronto case-control study.
Clarke EA; Hilditch S; Anderson TW
IARC Sci Publ; 1986; (76):125-31. PubMed ID: 3570399
[TBL] [Abstract][Full Text] [Related]
24. Screening hospital patients for uterine cervical cancer.
Hudson E; Hewertson S; Jansz C; Gordon H
J Clin Pathol; 1983 Jun; 36(6):611-5. PubMed ID: 6853729
[TBL] [Abstract][Full Text] [Related]
25. [Changes in awareness of cervical cancer patients after medical treatments and the correlation of cervical screening situation and clinical stage at consultation].
Wang CF; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):361-3. PubMed ID: 22883525
[TBL] [Abstract][Full Text] [Related]
26. Cervical cancer screening. Organised screening to avoid unnecessary conisation.
Prescrire Int; 2010 Aug; 19(108):172-7, 179. PubMed ID: 20939454
[TBL] [Abstract][Full Text] [Related]
27. [Cytological history of cases of invasive cervical cancer diagnosed in France in 2006].
Boulanger JC; Fauvet R; Urrutiaguer S; Drean Y; Sevestre H; Ganry O; Bergeron C; Gondry J
Gynecol Obstet Fertil; 2007 Sep; 35(9):764-71. PubMed ID: 17765001
[TBL] [Abstract][Full Text] [Related]
28. Prophylactic cytological investigation for cervical cancer in relation to stage at diagnosis: a study of 420 women in Denmark.
Olesen F
J R Coll Gen Pract; 1988 Aug; 38(313):356-9. PubMed ID: 3256647
[TBL] [Abstract][Full Text] [Related]
29. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
30. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
31. Combined analysis of data from north-east Scotland and Iceland.
Moss S
IARC Sci Publ; 1986; (76):43-6. PubMed ID: 3570414
[No Abstract] [Full Text] [Related]
32. Association between cervical screening and prevention of invasive cervical cancer in Ontario: a population-based case-control study.
Vicus D; Sutradhar R; Lu Y; Kupets R; Paszat L;
Int J Gynecol Cancer; 2015 Jan; 25(1):106-11. PubMed ID: 25377725
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer screening in Japan. A case-control study.
Sato S; Makino H; Yajima A; Fukao A
Acta Cytol; 1997; 41(4):1103-6. PubMed ID: 9250306
[TBL] [Abstract][Full Text] [Related]
34. Appropriate frequency of mass-screening for uterine cervical cancer.
Iwanari O
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Oct; 39(10):1799-805. PubMed ID: 3429977
[TBL] [Abstract][Full Text] [Related]
35. Papanicolaou smear screening and cervical cancer. What can you expect?
Stenkvist B; Bergström R; Eklund G; Fox CH
JAMA; 1984 Sep; 252(11):1423-6. PubMed ID: 6471269
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of mass screening for cervical cancer in Shiga Prefecture].
Ishiguro T; Yoshida Y; Tenzaki T; Tanaka B
Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):655-60. PubMed ID: 6864024
[TBL] [Abstract][Full Text] [Related]
37. Nonattendance is still the main limitation for the effectiveness of screening for cervical cancer in the Netherlands.
Bos AB; Rebolj M; Habbema JD; van Ballegooijen M
Int J Cancer; 2006 Nov; 119(10):2372-5. PubMed ID: 16858676
[TBL] [Abstract][Full Text] [Related]
38. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
Schindeler S; Morrell S; Zuo Y; Baker D
J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
[TBL] [Abstract][Full Text] [Related]
39. [Consequences of incorrect interpretation of vaginal smear tests in a screening program].
Lynge E; Arffmann E; Poll P; Andersen PK
Ugeskr Laeger; 1994 Apr; 156(17):2594-6. PubMed ID: 8016968
[TBL] [Abstract][Full Text] [Related]
40. Cytological screening history of patients with early invasive cervical cancer.
Turner MJ; Keane DP; Flannelly GM; Lenehan PM; Murphy JF; Foley ME
Ir Med J; 1990 Jun; 83(2):61-2. PubMed ID: 2202697
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
